These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022 [TBL] [Abstract][Full Text] [Related]
3. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates. Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301 [TBL] [Abstract][Full Text] [Related]
4. Ablation of recurrent primary liver cancer using 131I-lipiodol. Novell R; Hilson A; Hobbs K Postgrad Med J; 1991 Apr; 67(786):393-5. PubMed ID: 1648718 [TBL] [Abstract][Full Text] [Related]
5. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study. Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004 [TBL] [Abstract][Full Text] [Related]
6. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259 [TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901 [TBL] [Abstract][Full Text] [Related]
18. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356 [TBL] [Abstract][Full Text] [Related]
19. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol. Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]